NCT06115213

Brief Summary

The North Kynouria Project was initiated to study cardiovascular/stroke risk factors by employing mass screening and long-term surveillance of an adult population in the municipality of North Kynouria, in the county of Arcadia, Peloponnese, Greece. The North Kynouria Study was initiated to assess modifiable and non-modifiable determinants of cerebrovascular and coronary heart disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
7,000

participants targeted

Target at P75+ for not_applicable cardiovascular-diseases

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

November 2, 2023

Status Verified

October 1, 2023

Enrollment Period

3.1 years

First QC Date

October 18, 2023

Last Update Submit

October 30, 2023

Conditions

Keywords

AtherosclerosisVascular DiseaseArterial Occlusive Diseases

Outcome Measures

Primary Outcomes (4)

  • Major adverse cardiovascular events

    myocardial infarction, ischemic and hemorrhagic stroke

    up to 5 years after enrollment

  • All-cause mortality

    Death by any cause, cardiovascular, infection, cancer, other

    up to 5 years after enrollment

  • Hospitalizations

    Any cause hospitalization

    up to 5 years after enrollment

  • Emergency room visits

    Any cause of emergency room visit

    up to 5 years after enrollment

Secondary Outcomes (5)

  • New diagnosis of Arterial hypertension

    up to 1 year after enrollment

  • New diagnosis of diabetes mellitus

    up to 1 year after enrollment

  • New diagnosis of dyslipidemia

    up to 1 year after enrollment

  • New diagnosis of carotid atherosclerosis

    up to 1 year after enrollment

  • New diagnosis of peripheral artery disease

    up to 1 year after enrollment

Study Arms (1)

Patient screening

EXPERIMENTAL

Single group, no masking, receiving the intervention

Behavioral: Patient counselling

Interventions

Patient counseling, lifestyle modifications, medication evaluation, and adherence

Also known as: lifestyle modifications, dietary recommendations, smoking cessation, physical activity recommendations, medication adherence
Patient screening

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • residents of North Kynouria

You may not qualify if:

  • under 18,
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Astros Health Care Center

Ástros, 220 01, Greece

RECRUITING

MeSH Terms

Conditions

Cardiovascular DiseasesHeart DiseasesCerebrovascular DisordersCoronary DiseaseDyslipidemiasStrokeMyocardial InfarctionHypertensionDiabetes MellitusPeripheral Arterial DiseaseAtherosclerosisVascular DiseasesArterial Occlusive Diseases

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesMyocardial IschemiaLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisGlucose Metabolism DisordersEndocrine System DiseasesArteriosclerosisPeripheral Vascular Diseases

Study Officials

  • Charalampos Milionis, MD, PhD

    University of Ioannina

    PRINCIPAL INVESTIGATOR
  • George Ntaios, MD, MSc, PhD

    University of Thessaly

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Charalampos Milionis, MD, PhD

CONTACT

George Ntaios, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MSc, PhD

Study Record Dates

First Submitted

October 18, 2023

First Posted

November 2, 2023

Study Start

November 1, 2022

Primary Completion

November 30, 2025

Study Completion

November 30, 2025

Last Updated

November 2, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Study protocol details

Shared Documents
STUDY PROTOCOL
Time Frame
2024-2025
Access Criteria
Through access granting from the University of Ioannina

Locations